Crown Bioscience
Global preclinical research organisation that provides drug discovery solutions for cancer and metabolic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€97—145m (Dealroom.co estimates May 2014.)
United States (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Spinout | |
N/A | N/A | Early VC | |
$3.2m | Series B | ||
$28.8m | Series C | ||
$26.6m | Series D | ||
Total Funding | €53.3m |
Recent News about Crown Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Crown Bioscience
EditACQUISITION by Crown Bioscience May 2021
ACQUISITION by Crown Bioscience Mar 2016